Extract notice to the Minister

Otulfi (APsO, CU, MC, PsO)

Common name / Subject : ustekinumab
Name of the manufacturer : Fresenius
Form : Sol. Inj. S.C. (ser); Sol. Perf. I.V. (fiole)
Dosage : ser : 45 mg / 0,5 ml - 90 mg/ 1 ml; fiole : 5 mg/ml (26 ml)

Indication : Médicament biosimilaire- Arthrite psoriasique, Colite ulcéreuse, Maladie de Crohn et Psoriasis en plaques

INESSS' Recommendation
Inscription - Sous conditions

Minister's decisions
À venir

Evaluation published on April 30, 2025

Download Advice to minister about Otulfi (APsO, CU, MC, PsO)

Extrait d'avis au ministre sur Otulfi 363 KiO

Subscribe to our newsletter now

Subscription